Jason Li, Ph.D
VP CMC Development
Jason Li, Ph.D, VP CMC Development
As VP of CMC at EpimAb Biotherapeutics Co., Ltd, Jason Li brings in 18 years hands-on and managerial experience in bioprocess design/development and cGMP clinical manufacturing of therapeutic proteins, and 8 years' experience in process analytical development. Before joining EpimAb, Jason was VP and Head of Process Development at Shanghai Henlius Inc. Prior to that, he held senior scientific/technical leadership positions in Wuxi Biologics Inc., NOVAVAX Inc. and The Dow Chemical Co. in the US. Jason received his Ph.D in Biochemistry from University of Poitiers in France in 1988.